A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children's Oncology Group AALL1732

被引：0
|
作者：
O'Brien, Maureen Megan
McNeer, Jennifer Lynn
Rheingold, Susan R.
Devidas, Meenakshi
Chen, Zhiguo
Bhojwani, Deepa
Ramsey, Laura B.
Agrawal, Anurag
Wood, Brent L.
Suh, Eugene
Alexander, Sarah
Miller, Tamara P.
Militano, Olga
Burke, Michael
Salzer, Wanda L.
Raetz, Elizabeth A.
Loh, Mignon L.
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Univ Chicago, Chicago, IL USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] St Jude Childrens Res Hosp, Memphis, TN USA
[5] Univ Florida, Dept Biostat, Gainesville, FL USA
[6] Childrens Hosp Los Angeles, Los Angeles, CA USA
[7] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[8] CHLA, Los Angeles, CA USA
[9] Loyola Univ, Med Ctr, Maywood, IL USA
[10] Hosp Sick Children, Toronto, ON, Canada
[11] Emory Univ, Atlanta, GA USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Med Coll Wisconsin, Milwaukee, WI USA
[14] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
[15] Perlmutter Canc Ctr, New York, NY USA
[16] NYU Langone, New York, NY USA
[17] Seattle Childrens Hosp, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10016
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children?s Oncology Group Trial AALL0331
    Maloney, Kelly W.
    Devidas, Meenakshi
    Wang, Cindy
    Mattano, Leonard A.
    Friedmann, Alison M.
    Buckley, Patrick
    Borowitz, Michael J.
    Carroll, Andrew J.
    Gastier-Foster, Julie M.
    Heerema, Nyla A.
    Kadan-Lottick, Nina
    Loh, Mignon L.
    Matloub, Yousif H.
    Marshall, David T.
    Stork, Linda C.
    Raetz, Elizabeth A.
    Wood, Brent
    Hunger, Stephen P.
    Carroll, William L.
    Winick, Naomi J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 602 - +
  • [22] Minimal residual disease at end of induction and consolidation remain important prognostic indicators for newly diagnosed children and young adults with very high-risk (VHR) B-lymphoblastic leukemia (B-ALL): Children's Oncology Group AALL1131.
    Salzer, Wanda L.
    Burke, Michael James
    Devidas, Meenakshi
    Dai, Yunfeng
    Heerema, Nyla A.
    Carroll, Andrew J.
    Gore, Lia
    Hilden, Joanne M.
    Larsen, Eric
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen
    Loh, Mignon L.
    Wood, Brent L.
    Borowitz, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Treatment-Related Mortality (TRM) in Children with Down Syndrome (DS) and B-Lymphoblastic Leukemia (B-ALL): An Interim Report from the Children's Oncology Group Trials AALL0932 and AALL1131
    Rabin, Karen R.
    Hitzler, Johann
    Rodriguez, Vilmarie
    Schore, Reuven
    Angiolillo, Anne
    Burke, Michael J.
    Salzer, Wanda
    Maloney, Kelly
    Lu, Xiaomin
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth
    Hunger, Stephen P.
    BLOOD, 2015, 126 (23)
  • [24] Updated Results of the Phase II Trial of Inotuzumab Ozogamicin (INO) Combined with Mini-Hyper-CVD As Salvage Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Assi, Rita
    Kantarjian, Hagop M.
    Khouri, Rita
    Ravandi, Farhad
    Kebriaei, Partow
    Short, Nicholas J.
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Champlin, Richard E.
    Kadia, Tapan
    Cortes, Jorge E.
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Takahashi, Koichi
    Sasaki, Koji
    Jacob, Jovitta
    Manzoor, Ameena
    Garris, Rebecca
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2017, 130
  • [25] Incidence of Allergic Reactions to Pegaspargase (PEG) Administered Intramuscularly Versus Intravenously (IM vs. IV) in Children and Young Adults with High Risk B-Lymphoblastic Leukemia (HR B-ALL): Results of Children's Oncology Group (COG) Studies AALL0232/AALL1131
    Salzer, Wanda
    Burke, Michael J.
    Larsen, Eric C.
    Chen, Si
    Gore, Lia
    Hilden, Joanne M.
    Loh, Mignon L.
    Raetz, Elizabeth
    Winick, Naomi J.
    Carroll, William L.
    Devidas, Meenakshi
    Hunger, Stephen P.
    BLOOD, 2015, 126 (23)
  • [26] Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group
    Horton, Terzah M.
    Whitlock, James A.
    Lu, Xiaomin
    O'Brien, Maureen M.
    Borowitz, Michael J.
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Brown, Patrick A.
    Carroll, William L.
    Hunger, Stephen P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (02) : 274 - 285
  • [27] Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma A Randomized Clinical Trial From the Children's Oncology Group
    Leary, Sarah E. S.
    Packer, Roger J.
    Li, Yimei
    Billups, Catherine A.
    Smith, Kyle S.
    Jaju, Alok
    Heier, Linda
    Burger, Peter
    Walsh, Karin
    Han, Yuanyuan
    Embry, Leanne
    Hadley, Jennifer
    Kumar, Rahul
    Michalski, Jeff
    Hwang, Eugene
    Gajjar, Amar
    Pollack, Ian F.
    Fouladi, Maryam
    Northcott, Paul A.
    Olson, James M.
    JAMA ONCOLOGY, 2021, 7 (09) : 1313 - 1321
  • [28] The significance of minimal residual disease (MRD) in relapsed childhood B-lymphoblastic leukemia (B-ALL): A report from Children's Oncology Group (COG) protocol AALL0433.
    Lew, Glen
    Lu, Xiaomin
    Yanofsky, Rochelle
    Rheingold, Susan R.
    Whitlock, James
    Gulig, Scott D.
    Devidas, Meenakshi
    Pulsipher, Michael
    Hastings, Caroline Aimee
    Winick, Naomi Joan
    Carroll, William L.
    Borowitz, Michael J.
    Hunger, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331
    Brown, Patrick A.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Hogan, Laura
    Borowitz, Michael J.
    Raetz, Elizabeth A.
    Zugmaier, Gerhard
    Sharon, Elad
    Gore, Lia
    Whitlock, James A.
    Pulsipher, Michael A.
    Hunger, Stephen P.
    Loh, Mignon L.
    BLOOD, 2019, 134
  • [30] EXCELLENT EVENT-FREE (EFS) AND OVERALL SURVIVAL (OS) FOR CHILDREN WITH DOWN SYNDROME (DS) WITH STANDARD RISK B-ACUTE LYMPHOBLASTIC LEUKEMIA (SR B-ALL): RESULTS OF CHILDREN'S ONCOLOGY GROUP (COG) AALL0331
    Maloney, Kelly
    Devidas, Meenakshi
    Mattano, Leonard
    Friedmann, Alison
    Rabin, Karen
    Buckley, Patrick
    Borowitz, Michael
    Carroll, Andrew
    Gastier-Foster, Julie
    Heerema, Nyla
    Kadan-Lottick, Nina
    Loh, Mignon
    Matloub, Yousif
    Marshall, David
    Stork, Linda
    Raetz, Elizabeth
    Wood, Brent
    Winick, Naomi
    Hunger, Stephen
    Carroll, William
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345